A number of new antidiabetes agents for type 2 diabetes have become available in recent years, and these have been
accompanied subsequently by updated guidance from bodies such as NICE.
Many of us working in the primary care setting have now used these newer agents, and this complimentary, topical, afternoon
update provides a welcome opportunity to share our clinical experiences and best practice findings. We shall also consider our
approach to treatment from the perspective of the priorities of the person with diabetes – something that must not be forgotten
in the midst of all the recent attention on therapeutics and glucose lowering targets.
Furthermore, we will offer a timely update for primary care practitioners on how to take a responsible approach to bariatric
surgery, and we will also consider the antidiabetes agents of the future. If you are a primary care practitioner involved in the
day-to-day management of type 2 diabetes, we look forward to welcoming you to what promises to be a most productive and
rewarding afternoon.

Graham Pogrel, GP, Millom, Cumbria

Date of preparation:  July 2010

07-11 JAN/32115-10